nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS8—optic choroid—melanoma	0.00913	0.0252	CbGeAlD
Metformin—NDUFA2—hair follicle—melanoma	0.00427	0.0118	CbGeAlD
Metformin—NDUFA10—hair follicle—melanoma	0.00408	0.0112	CbGeAlD
Metformin—NDUFC1—hair follicle—melanoma	0.00404	0.0111	CbGeAlD
Metformin—NDUFB2—hair follicle—melanoma	0.004	0.011	CbGeAlD
Metformin—NDUFB3—hair follicle—melanoma	0.00391	0.0108	CbGeAlD
Metformin—NDUFB6—hair follicle—melanoma	0.00379	0.0104	CbGeAlD
Metformin—NDUFB1—hair follicle—melanoma	0.00368	0.0102	CbGeAlD
Metformin—NDUFB5—hair follicle—melanoma	0.00363	0.01	CbGeAlD
Metformin—NDUFA6—hair follicle—melanoma	0.00363	0.01	CbGeAlD
Metformin—NDUFS4—hair follicle—melanoma	0.00361	0.00995	CbGeAlD
Metformin—NDUFB4—hair follicle—melanoma	0.00356	0.00982	CbGeAlD
Metformin—NDUFAB1—hair follicle—melanoma	0.00354	0.00976	CbGeAlD
Metformin—NDUFA8—hair follicle—melanoma	0.00352	0.0097	CbGeAlD
Metformin—NDUFA4—hair follicle—melanoma	0.0035	0.00964	CbGeAlD
Metformin—NDUFV1—hair follicle—melanoma	0.00348	0.00959	CbGeAlD
Metformin—NDUFB11—hair follicle—melanoma	0.00348	0.00959	CbGeAlD
Metformin—NDUFA13—neck—melanoma	0.00346	0.00954	CbGeAlD
Metformin—NDUFS5—hair follicle—melanoma	0.00345	0.00953	CbGeAlD
Metformin—NDUFB8—hair follicle—melanoma	0.00345	0.00953	CbGeAlD
Metformin—ND3—neck—melanoma	0.00302	0.00834	CbGeAlD
Metformin—ND2—neck—melanoma	0.00302	0.00834	CbGeAlD
Metformin—ND4L—neck—melanoma	0.00302	0.00834	CbGeAlD
Metformin—ND5—neck—melanoma	0.00302	0.00834	CbGeAlD
Metformin—SLC29A4—eye—melanoma	0.00293	0.00809	CbGeAlD
Metformin—ND4—neck—melanoma	0.00293	0.00807	CbGeAlD
Metformin—NDUFS6—skin of body—melanoma	0.00275	0.00757	CbGeAlD
Metformin—NDUFB2—neck—melanoma	0.00269	0.00741	CbGeAlD
Metformin—NDUFS2—hair follicle—melanoma	0.00268	0.0074	CbGeAlD
Metformin—NDUFS3—hair follicle—melanoma	0.00265	0.00731	CbGeAlD
Metformin—ND6—neck—melanoma	0.00264	0.00729	CbGeAlD
Metformin—NDUFA5—neck—melanoma	0.00256	0.00706	CbGeAlD
Metformin—NDUFA1—eye—melanoma	0.00253	0.00699	CbGeAlD
Metformin—NDUFS4—neck—melanoma	0.00242	0.00668	CbGeAlD
Metformin—NDUFB4—neck—melanoma	0.00239	0.00659	CbGeAlD
Metformin—NDUFA4L2—retina—melanoma	0.00237	0.00654	CbGeAlD
Metformin—NDUFA4—neck—melanoma	0.00235	0.00647	CbGeAlD
Metformin—NDUFV1—neck—melanoma	0.00233	0.00643	CbGeAlD
Metformin—NDUFS5—neck—melanoma	0.00232	0.00639	CbGeAlD
Metformin—NDUFA9—skin of body—melanoma	0.00224	0.00617	CbGeAlD
Metformin—NDUFA13—skin of body—melanoma	0.00224	0.00617	CbGeAlD
Metformin—ND4—eye—melanoma	0.00218	0.006	CbGeAlD
Metformin—ND4—retina—melanoma	0.00216	0.00595	CbGeAlD
Metformin—ND6—eye—melanoma	0.00197	0.00542	CbGeAlD
Metformin—NDUFAF1—retina—melanoma	0.00196	0.00542	CbGeAlD
Metformin—ND4L—skin of body—melanoma	0.00196	0.0054	CbGeAlD
Metformin—ND3—skin of body—melanoma	0.00196	0.0054	CbGeAlD
Metformin—ND2—skin of body—melanoma	0.00196	0.0054	CbGeAlD
Metformin—ND5—skin of body—melanoma	0.00196	0.0054	CbGeAlD
Metformin—NDUFAF2—eye—melanoma	0.00195	0.00538	CbGeAlD
Metformin—ND6—retina—melanoma	0.00195	0.00537	CbGeAlD
Metformin—NDUFA5—eye—melanoma	0.00191	0.00525	CbGeAlD
Metformin—NDUFA11—eye—melanoma	0.00191	0.00525	CbGeAlD
Metformin—NDUFA4L2—mammalian vulva—melanoma	0.0019	0.00524	CbGeAlD
Metformin—ND4—skin of body—melanoma	0.00189	0.00522	CbGeAlD
Metformin—NDUFA5—retina—melanoma	0.00189	0.00521	CbGeAlD
Metformin—NDUFA11—retina—melanoma	0.00189	0.00521	CbGeAlD
Metformin—NDUFS1—eye—melanoma	0.00188	0.00518	CbGeAlD
Metformin—NDUFAF4—retina—melanoma	0.00187	0.00517	CbGeAlD
Metformin—NDUFC2—neck—melanoma	0.00187	0.00516	CbGeAlD
Metformin—NDUFS1—retina—melanoma	0.00186	0.00513	CbGeAlD
Metformin—NDUFA12—eye—melanoma	0.00185	0.0051	CbGeAlD
Metformin—NDUFV3—head—melanoma	0.00184	0.00508	CbGeAlD
Metformin—NDUFS8—eye—melanoma	0.00184	0.00507	CbGeAlD
Metformin—NDUFA12—retina—melanoma	0.00183	0.00506	CbGeAlD
Metformin—NDUFS8—retina—melanoma	0.00182	0.00502	CbGeAlD
Metformin—NDUFS4—eye—melanoma	0.0018	0.00497	CbGeAlD
Metformin—NDUFB5—retina—melanoma	0.0018	0.00496	CbGeAlD
Metformin—NDUFS6—head—melanoma	0.00179	0.00494	CbGeAlD
Metformin—NDUFA10—skin of body—melanoma	0.00177	0.00488	CbGeAlD
Metformin—NDUFA8—eye—melanoma	0.00176	0.00484	CbGeAlD
Metformin—NDUFC1—skin of body—melanoma	0.00175	0.00484	CbGeAlD
Metformin—NDUFA4—eye—melanoma	0.00175	0.00481	CbGeAlD
Metformin—NDUFA8—retina—melanoma	0.00174	0.0048	CbGeAlD
Metformin—NDUFV1—eye—melanoma	0.00173	0.00478	CbGeAlD
Metformin—NDUFB11—eye—melanoma	0.00173	0.00478	CbGeAlD
Metformin—NDUFS5—eye—melanoma	0.00172	0.00476	CbGeAlD
Metformin—NDUFB8—eye—melanoma	0.00172	0.00476	CbGeAlD
Metformin—ND6—skin of body—melanoma	0.00171	0.00472	CbGeAlD
Metformin—NDUFB8—retina—melanoma	0.00171	0.00471	CbGeAlD
Metformin—SLC29A4—head—melanoma	0.00167	0.00459	CbGeAlD
Metformin—NDUFA5—skin of body—melanoma	0.00166	0.00457	CbGeAlD
Metformin—NDUFB6—skin of body—melanoma	0.00165	0.00454	CbGeAlD
Metformin—NDUFS1—skin of body—melanoma	0.00163	0.0045	CbGeAlD
Metformin—NDUFAF3—head—melanoma	0.00163	0.0045	CbGeAlD
Metformin—NDUFB10—skin of body—melanoma	0.00162	0.00447	CbGeAlD
Metformin—NDUFC1—mammalian vulva—melanoma	0.0016	0.00441	CbGeAlD
Metformin—NDUFB5—skin of body—melanoma	0.00158	0.00435	CbGeAlD
Metformin—NDUFAF1—mammalian vulva—melanoma	0.00157	0.00434	CbGeAlD
Metformin—NDUFAF2—mammalian vulva—melanoma	0.00155	0.00427	CbGeAlD
Metformin—NDUFB3—mammalian vulva—melanoma	0.00155	0.00427	CbGeAlD
Metformin—NDUFAB1—skin of body—melanoma	0.00154	0.00424	CbGeAlD
Metformin—NDUFB9—skin of body—melanoma	0.00153	0.00421	CbGeAlD
Metformin—NDUFA4—skin of body—melanoma	0.00152	0.00419	CbGeAlD
Metformin—NDUFA5—mammalian vulva—melanoma	0.00151	0.00417	CbGeAlD
Metformin—NDUFV1—skin of body—melanoma	0.00151	0.00416	CbGeAlD
Metformin—NDUFAF4—mammalian vulva—melanoma	0.0015	0.00414	CbGeAlD
Metformin—NDUFB6—mammalian vulva—melanoma	0.0015	0.00414	CbGeAlD
Metformin—NDUFS5—skin of body—melanoma	0.0015	0.00414	CbGeAlD
Metformin—NDUFB8—skin of body—melanoma	0.0015	0.00414	CbGeAlD
Metformin—NDUFB10—mammalian vulva—melanoma	0.00148	0.00408	CbGeAlD
Metformin—PRKAB1—eye—melanoma	0.00148	0.00408	CbGeAlD
Metformin—ND1—neck—melanoma	0.00148	0.00407	CbGeAlD
Metformin—NDUFA12—mammalian vulva—melanoma	0.00147	0.00405	CbGeAlD
Metformin—NDUFB7—mammalian vulva—melanoma	0.00147	0.00405	CbGeAlD
Metformin—PRKAB1—retina—melanoma	0.00146	0.00404	CbGeAlD
Metformin—NDUFA13—head—melanoma	0.00146	0.00403	CbGeAlD
Metformin—NDUFA9—head—melanoma	0.00146	0.00403	CbGeAlD
Metformin—NDUFB1—mammalian vulva—melanoma	0.00146	0.00402	CbGeAlD
Metformin—NDUFS8—mammalian vulva—melanoma	0.00146	0.00402	CbGeAlD
Metformin—NDUFA6—mammalian vulva—melanoma	0.00144	0.00397	CbGeAlD
Metformin—NDUFB5—mammalian vulva—melanoma	0.00144	0.00397	CbGeAlD
Metformin—NDUFA1—head—melanoma	0.00144	0.00397	CbGeAlD
Metformin—NDUFS4—mammalian vulva—melanoma	0.00143	0.00394	CbGeAlD
Metformin—NDUFB4—mammalian vulva—melanoma	0.00141	0.00389	CbGeAlD
Metformin—NDUFAB1—mammalian vulva—melanoma	0.0014	0.00387	CbGeAlD
Metformin—NDUFV2—head—melanoma	0.0014	0.00385	CbGeAlD
Metformin—NDUFB9—mammalian vulva—melanoma	0.00139	0.00384	CbGeAlD
Metformin—NDUFA8—mammalian vulva—melanoma	0.00139	0.00384	CbGeAlD
Metformin—NDUFC2—eye—melanoma	0.00139	0.00384	CbGeAlD
Metformin—NDUFA4—mammalian vulva—melanoma	0.00138	0.00382	CbGeAlD
Metformin—NDUFC2—retina—melanoma	0.00138	0.00381	CbGeAlD
Metformin—NDUFB11—mammalian vulva—melanoma	0.00138	0.0038	CbGeAlD
Metformin—NDUFV1—mammalian vulva—melanoma	0.00138	0.0038	CbGeAlD
Metformin—NDUFS5—mammalian vulva—melanoma	0.00137	0.00377	CbGeAlD
Metformin—NDUFB8—mammalian vulva—melanoma	0.00137	0.00377	CbGeAlD
Metformin—NDUFS2—eye—melanoma	0.00134	0.00369	CbGeAlD
Metformin—Malnutrition—Vemurafenib—melanoma	0.00134	0.00668	CcSEcCtD
Metformin—Ear pain—Temozolomide—melanoma	0.00133	0.00664	CcSEcCtD
Metformin—NDUFS2—retina—melanoma	0.00133	0.00366	CbGeAlD
Metformin—Dysgeusia—Vemurafenib—melanoma	0.00131	0.00654	CcSEcCtD
Metformin—Rhinorrhoea—Docetaxel—melanoma	0.00128	0.00641	CcSEcCtD
Metformin—Lethargy—Dactinomycin—melanoma	0.00128	0.00639	CcSEcCtD
Metformin—Injury—Carmustine—melanoma	0.00128	0.00638	CcSEcCtD
Metformin—ND4L—head—melanoma	0.00128	0.00352	CbGeAlD
Metformin—ND3—head—melanoma	0.00128	0.00352	CbGeAlD
Metformin—ND5—head—melanoma	0.00128	0.00352	CbGeAlD
Metformin—ND2—head—melanoma	0.00128	0.00352	CbGeAlD
Metformin—Rigors—Docetaxel—melanoma	0.00127	0.00636	CcSEcCtD
Metformin—Nasal congestion—Temozolomide—melanoma	0.00125	0.00622	CcSEcCtD
Metformin—ND4—head—melanoma	0.00124	0.00341	CbGeAlD
Metformin—NDUFA7—lymph node—melanoma	0.00122	0.00337	CbGeAlD
Metformin—Chest discomfort—Docetaxel—melanoma	0.00118	0.00587	CcSEcCtD
Metformin—PRKAB1—mammalian vulva—melanoma	0.00117	0.00323	CbGeAlD
Metformin—NDUFS2—skin of body—melanoma	0.00116	0.00321	CbGeAlD
Metformin—Liver function test abnormal—Dactinomycin—melanoma	0.00116	0.00578	CcSEcCtD
Metformin—NDUFA10—head—melanoma	0.00115	0.00318	CbGeAlD
Metformin—NDUFS3—skin of body—melanoma	0.00115	0.00317	CbGeAlD
Metformin—NDUFC1—head—melanoma	0.00114	0.00316	CbGeAlD
Metformin—Myalgia—Vemurafenib—melanoma	0.00114	0.00568	CcSEcCtD
Metformin—NDUFB2—head—melanoma	0.00113	0.00313	CbGeAlD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00113	0.00564	CcSEcCtD
Metformin—NDUFAF1—head—melanoma	0.00113	0.0031	CbGeAlD
Metformin—ND6—head—melanoma	0.00112	0.00308	CbGeAlD
Metformin—NDUFAF2—head—melanoma	0.00111	0.00305	CbGeAlD
Metformin—NDUFC2—mammalian vulva—melanoma	0.0011	0.00305	CbGeAlD
Metformin—Infection—Vemurafenib—melanoma	0.00108	0.00541	CcSEcCtD
Metformin—Liver function test abnormal—Carmustine—melanoma	0.00108	0.00541	CcSEcCtD
Metformin—NDUFA5—head—melanoma	0.00108	0.00298	CbGeAlD
Metformin—NDUFA11—head—melanoma	0.00108	0.00298	CbGeAlD
Metformin—NDUFB6—head—melanoma	0.00107	0.00296	CbGeAlD
Metformin—NDUFAF4—head—melanoma	0.00107	0.00296	CbGeAlD
Metformin—Nervous system disorder—Vemurafenib—melanoma	0.00107	0.00534	CcSEcCtD
Metformin—NDUFS1—head—melanoma	0.00107	0.00294	CbGeAlD
Metformin—NDUFS2—mammalian vulva—melanoma	0.00106	0.00293	CbGeAlD
Metformin—Skin disorder—Vemurafenib—melanoma	0.00106	0.00529	CcSEcCtD
Metformin—NDUFB10—head—melanoma	0.00106	0.00292	CbGeAlD
Metformin—Dehydration—Temozolomide—melanoma	0.00106	0.00527	CcSEcCtD
Metformin—NDUFB7—head—melanoma	0.00105	0.0029	CbGeAlD
Metformin—NDUFA12—head—melanoma	0.00105	0.0029	CbGeAlD
Metformin—NDUFS3—mammalian vulva—melanoma	0.00105	0.00289	CbGeAlD
Metformin—NDUFB1—head—melanoma	0.00104	0.00288	CbGeAlD
Metformin—NDUFS8—head—melanoma	0.00104	0.00288	CbGeAlD
Metformin—NDUFB5—head—melanoma	0.00103	0.00284	CbGeAlD
Metformin—NDUFA6—head—melanoma	0.00103	0.00284	CbGeAlD
Metformin—Breast disorder—Temozolomide—melanoma	0.00103	0.00512	CcSEcCtD
Metformin—NDUFS4—head—melanoma	0.00102	0.00282	CbGeAlD
Metformin—Hypotension—Vemurafenib—melanoma	0.00102	0.00509	CcSEcCtD
Metformin—Neutropenia—Dactinomycin—melanoma	0.00101	0.00506	CcSEcCtD
Metformin—NDUFB4—head—melanoma	0.00101	0.00278	CbGeAlD
Metformin—NDUFAB1—head—melanoma	0.001	0.00277	CbGeAlD
Metformin—NDUFB9—head—melanoma	0.000997	0.00275	CbGeAlD
Metformin—NDUFA8—head—melanoma	0.000997	0.00275	CbGeAlD
Metformin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000995	0.00496	CcSEcCtD
Metformin—NDUFA4—head—melanoma	0.000991	0.00273	CbGeAlD
Metformin—Abdominal distension—Temozolomide—melanoma	0.000988	0.00493	CcSEcCtD
Metformin—NDUFB11—head—melanoma	0.000985	0.00272	CbGeAlD
Metformin—NDUFV1—head—melanoma	0.000985	0.00272	CbGeAlD
Metformin—NDUFB8—head—melanoma	0.000979	0.0027	CbGeAlD
Metformin—NDUFS5—head—melanoma	0.000979	0.0027	CbGeAlD
Metformin—NDUFV2—lymph node—melanoma	0.000977	0.0027	CbGeAlD
Metformin—Neuropathy—Docetaxel—melanoma	0.000977	0.00487	CcSEcCtD
Metformin—Sweating increased—Temozolomide—melanoma	0.000956	0.00477	CcSEcCtD
Metformin—ND1—skin of body—melanoma	0.000956	0.00264	CbGeAlD
Metformin—NDUFA4L2—lymph node—melanoma	0.000951	0.00262	CbGeAlD
Metformin—Neutropenia—Carmustine—melanoma	0.000949	0.00474	CcSEcCtD
Metformin—Decreased appetite—Vemurafenib—melanoma	0.000949	0.00474	CcSEcCtD
Metformin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000943	0.0047	CcSEcCtD
Metformin—Fatigue—Vemurafenib—melanoma	0.000941	0.0047	CcSEcCtD
Metformin—Constipation—Vemurafenib—melanoma	0.000934	0.00466	CcSEcCtD
Metformin—Lightheadedness—Docetaxel—melanoma	0.000931	0.00464	CcSEcCtD
Metformin—Hypoaesthesia—Bleomycin—melanoma	0.000926	0.00462	CcSEcCtD
Metformin—Neutropenia—Temozolomide—melanoma	0.000918	0.00458	CcSEcCtD
Metformin—NDUFS7—head—melanoma	0.000917	0.00253	CbGeAlD
Metformin—Upper respiratory tract infection—Temozolomide—melanoma	0.000912	0.00455	CcSEcCtD
Metformin—ND4L—lymph node—melanoma	0.000894	0.00247	CbGeAlD
Metformin—ND2—lymph node—melanoma	0.000894	0.00247	CbGeAlD
Metformin—ND5—lymph node—melanoma	0.000894	0.00247	CbGeAlD
Metformin—ND3—lymph node—melanoma	0.000894	0.00247	CbGeAlD
Metformin—Neuropathy peripheral—Carmustine—melanoma	0.000887	0.00443	CcSEcCtD
Metformin—Infestation NOS—Temozolomide—melanoma	0.000875	0.00437	CcSEcCtD
Metformin—Infestation—Temozolomide—melanoma	0.000875	0.00437	CcSEcCtD
Metformin—Hepatitis—Dactinomycin—melanoma	0.000868	0.00433	CcSEcCtD
Metformin—ND4—lymph node—melanoma	0.000865	0.00239	CbGeAlD
Metformin—Flushing—Bleomycin—melanoma	0.000864	0.00431	CcSEcCtD
Metformin—Neuropathy peripheral—Temozolomide—melanoma	0.000858	0.00428	CcSEcCtD
Metformin—NDUFA2—lymph node—melanoma	0.000847	0.00234	CbGeAlD
Metformin—PRKAB1—head—melanoma	0.000839	0.00231	CbGeAlD
Metformin—Chills—Bleomycin—melanoma	0.000835	0.00417	CcSEcCtD
Metformin—Hepatobiliary disease—Temozolomide—melanoma	0.000827	0.00413	CcSEcCtD
Metformin—Erythema—Bleomycin—melanoma	0.000811	0.00404	CcSEcCtD
Metformin—Hypoaesthesia—Carmustine—melanoma	0.000809	0.00404	CcSEcCtD
Metformin—NDUFA10—lymph node—melanoma	0.000808	0.00223	CbGeAlD
Metformin—Flushing—Dactinomycin—melanoma	0.000806	0.00402	CcSEcCtD
Metformin—NDUFC1—lymph node—melanoma	0.000801	0.00221	CbGeAlD
Metformin—Oedema peripheral—Carmustine—melanoma	0.000801	0.004	CcSEcCtD
Metformin—Connective tissue disorder—Carmustine—melanoma	0.000799	0.00399	CcSEcCtD
Metformin—NDUFB2—lymph node—melanoma	0.000795	0.00219	CbGeAlD
Metformin—Renal impairment—Docetaxel—melanoma	0.000793	0.00396	CcSEcCtD
Metformin—NDUFC2—head—melanoma	0.000791	0.00218	CbGeAlD
Metformin—NDUFAF1—lymph node—melanoma	0.000788	0.00217	CbGeAlD
Metformin—Hepatitis—Temozolomide—melanoma	0.000785	0.00392	CcSEcCtD
Metformin—Asthenia—Vemurafenib—melanoma	0.000783	0.00391	CcSEcCtD
Metformin—Hypoaesthesia—Temozolomide—melanoma	0.000781	0.0039	CcSEcCtD
Metformin—ND6—lymph node—melanoma	0.000781	0.00216	CbGeAlD
Metformin—Chills—Dactinomycin—melanoma	0.000779	0.00389	CcSEcCtD
Metformin—NDUFB3—lymph node—melanoma	0.000775	0.00214	CbGeAlD
Metformin—NDUFAF2—lymph node—melanoma	0.000775	0.00214	CbGeAlD
Metformin—Oedema peripheral—Temozolomide—melanoma	0.000774	0.00386	CcSEcCtD
Metformin—Pruritus—Vemurafenib—melanoma	0.000772	0.00386	CcSEcCtD
Metformin—Connective tissue disorder—Temozolomide—melanoma	0.000772	0.00385	CcSEcCtD
Metformin—Lethargy—Docetaxel—melanoma	0.00077	0.00384	CcSEcCtD
Metformin—NDUFS2—head—melanoma	0.00076	0.0021	CbGeAlD
Metformin—Eye disorder—Carmustine—melanoma	0.00076	0.00379	CcSEcCtD
Metformin—NDUFA5—lymph node—melanoma	0.000757	0.00209	CbGeAlD
Metformin—NDUFA11—lymph node—melanoma	0.000757	0.00209	CbGeAlD
Metformin—Erythema—Dactinomycin—melanoma	0.000756	0.00377	CcSEcCtD
Metformin—Pain in extremity—Docetaxel—melanoma	0.000755	0.00377	CcSEcCtD
Metformin—Flushing—Carmustine—melanoma	0.000754	0.00376	CcSEcCtD
Metformin—Ill-defined disorder—Bleomycin—melanoma	0.000752	0.00375	CcSEcCtD
Metformin—NDUFAF4—lymph node—melanoma	0.000752	0.00207	CbGeAlD
Metformin—NDUFB6—lymph node—melanoma	0.000752	0.00207	CbGeAlD
Metformin—NDUFS3—head—melanoma	0.000751	0.00207	CbGeAlD
Metformin—Diarrhoea—Vemurafenib—melanoma	0.000747	0.00373	CcSEcCtD
Metformin—SLC47A1—eye—melanoma	0.000746	0.00206	CbGeAlD
Metformin—NDUFS1—lymph node—melanoma	0.000746	0.00206	CbGeAlD
Metformin—Migraine—Docetaxel—melanoma	0.000743	0.00371	CcSEcCtD
Metformin—NDUFB10—lymph node—melanoma	0.000741	0.00204	CbGeAlD
Metformin—NDUFB7—lymph node—melanoma	0.000736	0.00203	CbGeAlD
Metformin—NDUFA12—lymph node—melanoma	0.000736	0.00203	CbGeAlD
Metformin—Eye disorder—Temozolomide—melanoma	0.000734	0.00366	CcSEcCtD
Metformin—Malaise—Bleomycin—melanoma	0.000731	0.00365	CcSEcCtD
Metformin—NDUFB1—lymph node—melanoma	0.00073	0.00201	CbGeAlD
Metformin—NDUFS8—lymph node—melanoma	0.00073	0.00201	CbGeAlD
Metformin—Flushing—Temozolomide—melanoma	0.000729	0.00364	CcSEcCtD
Metformin—Cardiac disorder—Temozolomide—melanoma	0.000729	0.00364	CcSEcCtD
Metformin—Dizziness—Vemurafenib—melanoma	0.000722	0.0036	CcSEcCtD
Metformin—NDUFB5—lymph node—melanoma	0.000721	0.00199	CbGeAlD
Metformin—NDUFA6—lymph node—melanoma	0.000721	0.00199	CbGeAlD
Metformin—NDUFS4—lymph node—melanoma	0.000716	0.00197	CbGeAlD
Metformin—Angiopathy—Temozolomide—melanoma	0.000713	0.00356	CcSEcCtD
Metformin—Immune system disorder—Temozolomide—melanoma	0.000709	0.00354	CcSEcCtD
Metformin—Mediastinal disorder—Temozolomide—melanoma	0.000708	0.00353	CcSEcCtD
Metformin—Malnutrition—Carmustine—melanoma	0.000708	0.00353	CcSEcCtD
Metformin—Erythema—Carmustine—melanoma	0.000708	0.00353	CcSEcCtD
Metformin—NDUFB4—lymph node—melanoma	0.000707	0.00195	CbGeAlD
Metformin—Chills—Temozolomide—melanoma	0.000705	0.00352	CcSEcCtD
Metformin—NDUFAB1—lymph node—melanoma	0.000702	0.00194	CbGeAlD
Metformin—Dehydration—Docetaxel—melanoma	0.000702	0.0035	CcSEcCtD
Metformin—Ill-defined disorder—Dactinomycin—melanoma	0.000701	0.0035	CcSEcCtD
Metformin—NDUFA8—lymph node—melanoma	0.000698	0.00192	CbGeAlD
Metformin—NDUFB9—lymph node—melanoma	0.000698	0.00192	CbGeAlD
Metformin—Liver function test abnormal—Docetaxel—melanoma	0.000697	0.00348	CcSEcCtD
Metformin—Vomiting—Vemurafenib—melanoma	0.000694	0.00346	CcSEcCtD
Metformin—NDUFA4—lymph node—melanoma	0.000694	0.00191	CbGeAlD
Metformin—Chest pain—Bleomycin—melanoma	0.00069	0.00344	CcSEcCtD
Metformin—Myalgia—Bleomycin—melanoma	0.00069	0.00344	CcSEcCtD
Metformin—Abdominal pain upper—Docetaxel—melanoma	0.00069	0.00344	CcSEcCtD
Metformin—NDUFV1—lymph node—melanoma	0.000689	0.0019	CbGeAlD
Metformin—NDUFB11—lymph node—melanoma	0.000689	0.0019	CbGeAlD
Metformin—Rash—Vemurafenib—melanoma	0.000688	0.00344	CcSEcCtD
Metformin—Dermatitis—Vemurafenib—melanoma	0.000688	0.00343	CcSEcCtD
Metformin—NDUFS5—lymph node—melanoma	0.000685	0.00189	CbGeAlD
Metformin—NDUFB8—lymph node—melanoma	0.000685	0.00189	CbGeAlD
Metformin—Headache—Vemurafenib—melanoma	0.000684	0.00341	CcSEcCtD
Metformin—Malnutrition—Temozolomide—melanoma	0.000684	0.00341	CcSEcCtD
Metformin—Erythema—Temozolomide—melanoma	0.000684	0.00341	CcSEcCtD
Metformin—Breast disorder—Docetaxel—melanoma	0.000682	0.0034	CcSEcCtD
Metformin—Discomfort—Bleomycin—melanoma	0.000682	0.0034	CcSEcCtD
Metformin—Malaise—Dactinomycin—melanoma	0.000682	0.0034	CcSEcCtD
Metformin—Cramp muscle—Docetaxel—melanoma	0.00068	0.00339	CcSEcCtD
Metformin—Nasopharyngitis—Docetaxel—melanoma	0.000675	0.00337	CcSEcCtD
Metformin—Dysgeusia—Temozolomide—melanoma	0.00067	0.00334	CcSEcCtD
Metformin—Vision blurred—Carmustine—melanoma	0.000667	0.00333	CcSEcCtD
Metformin—Tremor—Carmustine—melanoma	0.000663	0.00331	CcSEcCtD
Metformin—Oedema—Bleomycin—melanoma	0.000662	0.0033	CcSEcCtD
Metformin—Infection—Bleomycin—melanoma	0.000657	0.00328	CcSEcCtD
Metformin—Nausea—Vemurafenib—melanoma	0.000649	0.00324	CcSEcCtD
Metformin—Thrombocytopenia—Bleomycin—melanoma	0.000648	0.00323	CcSEcCtD
Metformin—Vision blurred—Temozolomide—melanoma	0.000644	0.00322	CcSEcCtD
Metformin—Myalgia—Dactinomycin—melanoma	0.000644	0.00321	CcSEcCtD
Metformin—NDUFS7—lymph node—melanoma	0.000642	0.00177	CbGeAlD
Metformin—Tremor—Temozolomide—melanoma	0.000641	0.0032	CcSEcCtD
Metformin—Discomfort—Dactinomycin—melanoma	0.000636	0.00317	CcSEcCtD
Metformin—Angina pectoris—Docetaxel—melanoma	0.000636	0.00317	CcSEcCtD
Metformin—Ill-defined disorder—Temozolomide—melanoma	0.000634	0.00317	CcSEcCtD
Metformin—Anorexia—Bleomycin—melanoma	0.000631	0.00315	CcSEcCtD
Metformin—ND1—head—melanoma	0.000623	0.00172	CbGeAlD
Metformin—Hypotension—Bleomycin—melanoma	0.000618	0.00308	CcSEcCtD
Metformin—Oedema—Dactinomycin—melanoma	0.000617	0.00308	CcSEcCtD
Metformin—Malaise—Temozolomide—melanoma	0.000617	0.00308	CcSEcCtD
Metformin—Infection—Dactinomycin—melanoma	0.000613	0.00306	CcSEcCtD
Metformin—Hypertension—Carmustine—melanoma	0.000611	0.00305	CcSEcCtD
Metformin—Neutropenia—Docetaxel—melanoma	0.00061	0.00305	CcSEcCtD
Metformin—Palpitations—Temozolomide—melanoma	0.000604	0.00302	CcSEcCtD
Metformin—Thrombocytopenia—Dactinomycin—melanoma	0.000604	0.00301	CcSEcCtD
Metformin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000603	0.00301	CcSEcCtD
Metformin—Myalgia—Carmustine—melanoma	0.000602	0.00301	CcSEcCtD
Metformin—Chest pain—Carmustine—melanoma	0.000602	0.00301	CcSEcCtD
Metformin—Paraesthesia—Bleomycin—melanoma	0.000594	0.00296	CcSEcCtD
Metformin—SLC47A1—mammalian vulva—melanoma	0.000592	0.00163	CbGeAlD
Metformin—Hypertension—Temozolomide—melanoma	0.00059	0.00295	CcSEcCtD
Metformin—Dyspnoea—Bleomycin—melanoma	0.00059	0.00294	CcSEcCtD
Metformin—Anorexia—Dactinomycin—melanoma	0.000588	0.00293	CcSEcCtD
Metformin—PRKAB1—lymph node—melanoma	0.000587	0.00162	CbGeAlD
Metformin—Myalgia—Temozolomide—melanoma	0.000582	0.0029	CcSEcCtD
Metformin—Infestation—Docetaxel—melanoma	0.000582	0.0029	CcSEcCtD
Metformin—Infestation NOS—Docetaxel—melanoma	0.000582	0.0029	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000578	0.00288	CcSEcCtD
Metformin—Oedema—Carmustine—melanoma	0.000577	0.00288	CcSEcCtD
Metformin—Discomfort—Temozolomide—melanoma	0.000575	0.00287	CcSEcCtD
Metformin—Decreased appetite—Bleomycin—melanoma	0.000575	0.00287	CcSEcCtD
Metformin—Infection—Carmustine—melanoma	0.000574	0.00286	CcSEcCtD
Metformin—Neuropathy peripheral—Docetaxel—melanoma	0.00057	0.00285	CcSEcCtD
Metformin—Thrombocytopenia—Carmustine—melanoma	0.000565	0.00282	CcSEcCtD
Metformin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000562	0.00281	CcSEcCtD
Metformin—Oedema—Temozolomide—melanoma	0.000558	0.00278	CcSEcCtD
Metformin—Infection—Temozolomide—melanoma	0.000554	0.00277	CcSEcCtD
Metformin—NDUFC2—lymph node—melanoma	0.000554	0.00153	CbGeAlD
Metformin—Anorexia—Carmustine—melanoma	0.00055	0.00275	CcSEcCtD
Metformin—Hepatobiliary disease—Docetaxel—melanoma	0.00055	0.00275	CcSEcCtD
Metformin—Nervous system disorder—Temozolomide—melanoma	0.000547	0.00273	CcSEcCtD
Metformin—Thrombocytopenia—Temozolomide—melanoma	0.000546	0.00273	CcSEcCtD
Metformin—Feeling abnormal—Bleomycin—melanoma	0.000545	0.00272	CcSEcCtD
Metformin—Skin disorder—Temozolomide—melanoma	0.000542	0.0027	CcSEcCtD
Metformin—Hypotension—Carmustine—melanoma	0.00054	0.00269	CcSEcCtD
Metformin—Hyperhidrosis—Temozolomide—melanoma	0.000539	0.00269	CcSEcCtD
Metformin—Decreased appetite—Dactinomycin—melanoma	0.000536	0.00268	CcSEcCtD
Metformin—NDUFS2—lymph node—melanoma	0.000532	0.00147	CbGeAlD
Metformin—Fatigue—Dactinomycin—melanoma	0.000532	0.00265	CcSEcCtD
Metformin—Anorexia—Temozolomide—melanoma	0.000532	0.00265	CcSEcCtD
Metformin—Musculoskeletal discomfort—Carmustine—melanoma	0.000526	0.00263	CcSEcCtD
Metformin—NDUFS3—lymph node—melanoma	0.000526	0.00145	CbGeAlD
Metformin—Urticaria—Bleomycin—melanoma	0.000526	0.00262	CcSEcCtD
Metformin—Rhinitis—Docetaxel—melanoma	0.000524	0.00261	CcSEcCtD
Metformin—Hepatitis—Docetaxel—melanoma	0.000522	0.00261	CcSEcCtD
Metformin—Hypoaesthesia—Docetaxel—melanoma	0.00052	0.00259	CcSEcCtD
Metformin—Paraesthesia—Carmustine—melanoma	0.000518	0.00259	CcSEcCtD
Metformin—Dyspnoea—Carmustine—melanoma	0.000515	0.00257	CcSEcCtD
Metformin—Oedema peripheral—Docetaxel—melanoma	0.000515	0.00257	CcSEcCtD
Metformin—Somnolence—Carmustine—melanoma	0.000513	0.00256	CcSEcCtD
Metformin—Connective tissue disorder—Docetaxel—melanoma	0.000513	0.00256	CcSEcCtD
Metformin—Feeling abnormal—Dactinomycin—melanoma	0.000508	0.00254	CcSEcCtD
Metformin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000508	0.00254	CcSEcCtD
Metformin—Gastrointestinal pain—Dactinomycin—melanoma	0.000504	0.00252	CcSEcCtD
Metformin—Decreased appetite—Carmustine—melanoma	0.000502	0.0025	CcSEcCtD
Metformin—Paraesthesia—Temozolomide—melanoma	0.000501	0.0025	CcSEcCtD
Metformin—Gastrointestinal disorder—Carmustine—melanoma	0.000499	0.00249	CcSEcCtD
Metformin—Dyspnoea—Temozolomide—melanoma	0.000497	0.00248	CcSEcCtD
Metformin—Somnolence—Temozolomide—melanoma	0.000496	0.00248	CcSEcCtD
Metformin—Constipation—Carmustine—melanoma	0.000494	0.00246	CcSEcCtD
Metformin—Dyspepsia—Temozolomide—melanoma	0.000491	0.00245	CcSEcCtD
Metformin—Eye disorder—Docetaxel—melanoma	0.000488	0.00244	CcSEcCtD
Metformin—Abdominal pain—Dactinomycin—melanoma	0.000488	0.00243	CcSEcCtD
Metformin—Decreased appetite—Temozolomide—melanoma	0.000485	0.00242	CcSEcCtD
Metformin—Cardiac disorder—Docetaxel—melanoma	0.000485	0.00242	CcSEcCtD
Metformin—Flushing—Docetaxel—melanoma	0.000485	0.00242	CcSEcCtD
Metformin—Gastrointestinal disorder—Temozolomide—melanoma	0.000482	0.0024	CcSEcCtD
Metformin—Fatigue—Temozolomide—melanoma	0.000481	0.0024	CcSEcCtD
Metformin—Constipation—Temozolomide—melanoma	0.000477	0.00238	CcSEcCtD
Metformin—Feeling abnormal—Carmustine—melanoma	0.000476	0.00237	CcSEcCtD
Metformin—Asthenia—Bleomycin—melanoma	0.000475	0.00237	CcSEcCtD
Metformin—Angiopathy—Docetaxel—melanoma	0.000474	0.00236	CcSEcCtD
Metformin—Gastrointestinal pain—Carmustine—melanoma	0.000472	0.00236	CcSEcCtD
Metformin—SLC22A3—mammalian vulva—melanoma	0.000472	0.0013	CbGeAlD
Metformin—Immune system disorder—Docetaxel—melanoma	0.000472	0.00235	CcSEcCtD
Metformin—Mediastinal disorder—Docetaxel—melanoma	0.000471	0.00235	CcSEcCtD
Metformin—Chills—Docetaxel—melanoma	0.000469	0.00234	CcSEcCtD
Metformin—Pruritus—Bleomycin—melanoma	0.000468	0.00234	CcSEcCtD
Metformin—Feeling abnormal—Temozolomide—melanoma	0.00046	0.00229	CcSEcCtD
Metformin—Abdominal pain—Carmustine—melanoma	0.000456	0.00228	CcSEcCtD
Metformin—Gastrointestinal pain—Temozolomide—melanoma	0.000456	0.00228	CcSEcCtD
Metformin—Erythema—Docetaxel—melanoma	0.000455	0.00227	CcSEcCtD
Metformin—Malnutrition—Docetaxel—melanoma	0.000455	0.00227	CcSEcCtD
Metformin—Dysgeusia—Docetaxel—melanoma	0.000445	0.00222	CcSEcCtD
Metformin—Urticaria—Temozolomide—melanoma	0.000443	0.00221	CcSEcCtD
Metformin—Asthenia—Dactinomycin—melanoma	0.000443	0.00221	CcSEcCtD
Metformin—Abdominal pain—Temozolomide—melanoma	0.000441	0.0022	CcSEcCtD
Metformin—Muscle spasms—Docetaxel—melanoma	0.000437	0.00218	CcSEcCtD
Metformin—ND1—lymph node—melanoma	0.000437	0.0012	CbGeAlD
Metformin—SLC47A1—head—melanoma	0.000424	0.00117	CbGeAlD
Metformin—Diarrhoea—Dactinomycin—melanoma	0.000422	0.00211	CcSEcCtD
Metformin—Vomiting—Bleomycin—melanoma	0.000421	0.0021	CcSEcCtD
Metformin—Rash—Bleomycin—melanoma	0.000417	0.00208	CcSEcCtD
Metformin—Dermatitis—Bleomycin—melanoma	0.000417	0.00208	CcSEcCtD
Metformin—Asthenia—Carmustine—melanoma	0.000414	0.00207	CcSEcCtD
Metformin—Syncope—Docetaxel—melanoma	0.000408	0.00203	CcSEcCtD
Metformin—Palpitations—Docetaxel—melanoma	0.000402	0.00201	CcSEcCtD
Metformin—Asthenia—Temozolomide—melanoma	0.0004	0.002	CcSEcCtD
Metformin—Loss of consciousness—Docetaxel—melanoma	0.0004	0.00199	CcSEcCtD
Metformin—Diarrhoea—Carmustine—melanoma	0.000395	0.00197	CcSEcCtD
Metformin—Pruritus—Temozolomide—melanoma	0.000395	0.00197	CcSEcCtD
Metformin—Nausea—Bleomycin—melanoma	0.000393	0.00196	CcSEcCtD
Metformin—Hypertension—Docetaxel—melanoma	0.000393	0.00196	CcSEcCtD
Metformin—Vomiting—Dactinomycin—melanoma	0.000392	0.00196	CcSEcCtD
Metformin—Rash—Dactinomycin—melanoma	0.000389	0.00194	CcSEcCtD
Metformin—Chest pain—Docetaxel—melanoma	0.000387	0.00193	CcSEcCtD
Metformin—Myalgia—Docetaxel—melanoma	0.000387	0.00193	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000384	0.00192	CcSEcCtD
Metformin—Dizziness—Carmustine—melanoma	0.000382	0.00191	CcSEcCtD
Metformin—Diarrhoea—Temozolomide—melanoma	0.000382	0.00191	CcSEcCtD
Metformin—Oedema—Docetaxel—melanoma	0.000371	0.00185	CcSEcCtD
Metformin—Dizziness—Temozolomide—melanoma	0.000369	0.00184	CcSEcCtD
Metformin—Infection—Docetaxel—melanoma	0.000369	0.00184	CcSEcCtD
Metformin—Vomiting—Carmustine—melanoma	0.000367	0.00183	CcSEcCtD
Metformin—Nausea—Dactinomycin—melanoma	0.000366	0.00183	CcSEcCtD
Metformin—Shock—Docetaxel—melanoma	0.000365	0.00182	CcSEcCtD
Metformin—Rash—Carmustine—melanoma	0.000364	0.00182	CcSEcCtD
Metformin—Nervous system disorder—Docetaxel—melanoma	0.000364	0.00182	CcSEcCtD
Metformin—Dermatitis—Carmustine—melanoma	0.000364	0.00182	CcSEcCtD
Metformin—Thrombocytopenia—Docetaxel—melanoma	0.000363	0.00181	CcSEcCtD
Metformin—Headache—Carmustine—melanoma	0.000362	0.00181	CcSEcCtD
Metformin—Skin disorder—Docetaxel—melanoma	0.00036	0.0018	CcSEcCtD
Metformin—Vomiting—Temozolomide—melanoma	0.000355	0.00177	CcSEcCtD
Metformin—Anorexia—Docetaxel—melanoma	0.000354	0.00177	CcSEcCtD
Metformin—SLC22A1—head—melanoma	0.000353	0.000975	CbGeAlD
Metformin—Rash—Temozolomide—melanoma	0.000352	0.00176	CcSEcCtD
Metformin—Dermatitis—Temozolomide—melanoma	0.000352	0.00175	CcSEcCtD
Metformin—Headache—Temozolomide—melanoma	0.00035	0.00174	CcSEcCtD
Metformin—Hypotension—Docetaxel—melanoma	0.000347	0.00173	CcSEcCtD
Metformin—Nausea—Carmustine—melanoma	0.000343	0.00171	CcSEcCtD
Metformin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000338	0.00169	CcSEcCtD
Metformin—SLC22A3—head—melanoma	0.000338	0.000932	CbGeAlD
Metformin—Paraesthesia—Docetaxel—melanoma	0.000333	0.00166	CcSEcCtD
Metformin—Nausea—Temozolomide—melanoma	0.000331	0.00165	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—melanoma	0.000331	0.00165	CcSEcCtD
Metformin—Somnolence—Docetaxel—melanoma	0.00033	0.00165	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—melanoma	0.000327	0.00163	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—melanoma	0.000323	0.00161	CcSEcCtD
Metformin—Gastrointestinal disorder—Docetaxel—melanoma	0.00032	0.0016	CcSEcCtD
Metformin—Fatigue—Docetaxel—melanoma	0.00032	0.0016	CcSEcCtD
Metformin—Constipation—Docetaxel—melanoma	0.000317	0.00158	CcSEcCtD
Metformin—Feeling abnormal—Docetaxel—melanoma	0.000306	0.00153	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—melanoma	0.000303	0.00151	CcSEcCtD
Metformin—SLC47A1—lymph node—melanoma	0.000297	0.000818	CbGeAlD
Metformin—Abdominal pain—Docetaxel—melanoma	0.000293	0.00146	CcSEcCtD
Metformin—Asthenia—Docetaxel—melanoma	0.000266	0.00133	CcSEcCtD
Metformin—Pruritus—Docetaxel—melanoma	0.000263	0.00131	CcSEcCtD
Metformin—Diarrhoea—Docetaxel—melanoma	0.000254	0.00127	CcSEcCtD
Metformin—Dizziness—Docetaxel—melanoma	0.000245	0.00122	CcSEcCtD
Metformin—SLC22A3—lymph node—melanoma	0.000237	0.000652	CbGeAlD
Metformin—Vomiting—Docetaxel—melanoma	0.000236	0.00118	CcSEcCtD
Metformin—Rash—Docetaxel—melanoma	0.000234	0.00117	CcSEcCtD
Metformin—Dermatitis—Docetaxel—melanoma	0.000234	0.00117	CcSEcCtD
Metformin—Headache—Docetaxel—melanoma	0.000232	0.00116	CcSEcCtD
Metformin—Nausea—Docetaxel—melanoma	0.00022	0.0011	CcSEcCtD
Metformin—SLC22A1—Metabolism—SLC6A11—melanoma	1.99e-05	4.54e-05	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—ALB—melanoma	1.95e-05	4.47e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CD86—melanoma	1.94e-05	4.44e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.94e-05	4.44e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTAP—melanoma	1.93e-05	4.42e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EDN1—melanoma	1.93e-05	4.41e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—melanoma	1.89e-05	4.31e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—melanoma	1.89e-05	4.31e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—melanoma	1.89e-05	4.31e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—melanoma	1.89e-05	4.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CSF2—melanoma	1.88e-05	4.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGF1—melanoma	1.88e-05	4.31e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—melanoma	1.88e-05	4.31e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—melanoma	1.88e-05	4.31e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—melanoma	1.88e-05	4.31e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—melanoma	1.86e-05	4.26e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PHGDH—melanoma	1.85e-05	4.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LUM—melanoma	1.85e-05	4.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—E2F1—melanoma	1.84e-05	4.22e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CG—melanoma	1.83e-05	4.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFRA—melanoma	1.82e-05	4.17e-05	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—ALB—melanoma	1.82e-05	4.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPSE—melanoma	1.81e-05	4.15e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ITGB3—melanoma	1.81e-05	4.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PRKCA—melanoma	1.81e-05	4.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CUBN—melanoma	1.78e-05	4.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SPP1—melanoma	1.77e-05	4.05e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—melanoma	1.77e-05	4.05e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—melanoma	1.77e-05	4.05e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAP2K2—melanoma	1.77e-05	4.04e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—melanoma	1.75e-05	4.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PHGDH—melanoma	1.72e-05	3.94e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LUM—melanoma	1.72e-05	3.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SDHD—melanoma	1.72e-05	3.93e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CSPG4—melanoma	1.72e-05	3.93e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BSG—melanoma	1.72e-05	3.93e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP17A1—melanoma	1.71e-05	3.91e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPSE—melanoma	1.69e-05	3.86e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—melanoma	1.68e-05	3.85e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—melanoma	1.68e-05	3.84e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—melanoma	1.67e-05	3.83e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RAC1—melanoma	1.67e-05	3.83e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPAM—melanoma	1.66e-05	3.81e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CUBN—melanoma	1.66e-05	3.79e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GNA11—melanoma	1.61e-05	3.69e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—melanoma	1.61e-05	3.69e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—melanoma	1.61e-05	3.67e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SDHD—melanoma	1.6e-05	3.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BSG—melanoma	1.6e-05	3.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CSPG4—melanoma	1.6e-05	3.66e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—melanoma	1.59e-05	3.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.59e-05	3.63e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—melanoma	1.58e-05	3.62e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—FASN—melanoma	1.58e-05	3.61e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—melanoma	1.56e-05	3.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—melanoma	1.56e-05	3.57e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC5A5—melanoma	1.55e-05	3.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPAM—melanoma	1.55e-05	3.55e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—melanoma	1.54e-05	3.52e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—melanoma	1.54e-05	3.52e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—melanoma	1.54e-05	3.52e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—melanoma	1.54e-05	3.52e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—melanoma	1.54e-05	3.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GNAQ—melanoma	1.5e-05	3.43e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CD44—melanoma	1.5e-05	3.43e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MAPK1—melanoma	1.49e-05	3.42e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—melanoma	1.48e-05	3.38e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FN1—melanoma	1.48e-05	3.38e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—melanoma	1.45e-05	3.31e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1B1—melanoma	1.44e-05	3.29e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—melanoma	1.43e-05	3.28e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CD80—melanoma	1.42e-05	3.24e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—melanoma	1.41e-05	3.24e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—melanoma	1.41e-05	3.24e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—melanoma	1.41e-05	3.24e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLA2G6—melanoma	1.41e-05	3.24e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—melanoma	1.4e-05	3.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGF—melanoma	1.4e-05	3.2e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MAPK1—melanoma	1.39e-05	3.19e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—melanoma	1.39e-05	3.18e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—melanoma	1.33e-05	3.04e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—melanoma	1.33e-05	3.04e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—melanoma	1.33e-05	3.04e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—melanoma	1.33e-05	3.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLA2G6—melanoma	1.32e-05	3.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1—melanoma	1.29e-05	2.96e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—melanoma	1.28e-05	2.92e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—VCAN—melanoma	1.27e-05	2.91e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAP2K1—melanoma	1.25e-05	2.86e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—melanoma	1.25e-05	2.86e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—melanoma	1.24e-05	2.84e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—melanoma	1.21e-05	2.78e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—melanoma	1.2e-05	2.74e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGF2—melanoma	1.19e-05	2.72e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—melanoma	1.18e-05	2.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—VCAN—melanoma	1.18e-05	2.71e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MAPK1—melanoma	1.14e-05	2.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—melanoma	1.12e-05	2.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—melanoma	1.11e-05	2.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—melanoma	1.1e-05	2.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PRKCA—melanoma	1.09e-05	2.49e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—melanoma	1.09e-05	2.48e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—melanoma	1.09e-05	2.48e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—melanoma	1.09e-05	2.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—melanoma	1.08e-05	2.48e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ERCC2—melanoma	1.08e-05	2.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP17A1—melanoma	1.07e-05	2.45e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MAPK1—melanoma	1.07e-05	2.44e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—melanoma	1.04e-05	2.38e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—melanoma	1.02e-05	2.33e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—melanoma	1.02e-05	2.33e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNA11—melanoma	1.01e-05	2.32e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP17A1—melanoma	9.99e-06	2.29e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—melanoma	9.97e-06	2.28e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—melanoma	9.95e-06	2.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	9.92e-06	2.27e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—FASN—melanoma	9.91e-06	2.27e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—melanoma	9.74e-06	2.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—melanoma	9.7e-06	2.22e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—melanoma	9.61e-06	2.2e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNA11—melanoma	9.43e-06	2.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—melanoma	9.42e-06	2.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CD44—melanoma	9.41e-06	2.15e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNAQ—melanoma	9.41e-06	2.15e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—melanoma	9.39e-06	2.15e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—melanoma	9.36e-06	2.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKB1—melanoma	9.32e-06	2.13e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	9.25e-06	2.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FASN—melanoma	9.23e-06	2.11e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—melanoma	9.19e-06	2.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—melanoma	9.08e-06	2.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1B1—melanoma	9.02e-06	2.06e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNAQ—melanoma	8.77e-06	2.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CD44—melanoma	8.77e-06	2.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—melanoma	8.57e-06	1.96e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—melanoma	8.56e-06	1.96e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—melanoma	8.54e-06	1.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—melanoma	8.46e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1B1—melanoma	8.41e-06	1.92e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—melanoma	8.38e-06	1.92e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—melanoma	8.35e-06	1.91e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—melanoma	8.24e-06	1.89e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—melanoma	8e-06	1.83e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—melanoma	7.78e-06	1.78e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK1—melanoma	7.61e-06	1.74e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—melanoma	7.61e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—melanoma	7.51e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—melanoma	7.43e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—melanoma	7.41e-06	1.7e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—melanoma	7.19e-06	1.65e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—melanoma	6.99e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—melanoma	6.92e-06	1.58e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PRKCA—melanoma	6.84e-06	1.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ERCC2—melanoma	6.78e-06	1.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—melanoma	6.61e-06	1.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—melanoma	6.54e-06	1.5e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—melanoma	6.48e-06	1.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—melanoma	6.39e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PRKCA—melanoma	6.37e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ERCC2—melanoma	6.32e-06	1.45e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—melanoma	6.11e-06	1.4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—melanoma	5.85e-06	1.34e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—melanoma	5.65e-06	1.29e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—melanoma	5.4e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—melanoma	5.36e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—melanoma	5.17e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—melanoma	4.99e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—melanoma	4.82e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—melanoma	4.71e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—melanoma	4.65e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—melanoma	4.39e-06	1e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—melanoma	4.33e-06	9.91e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—melanoma	4.1e-06	9.39e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—melanoma	4.07e-06	9.3e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—melanoma	3.99e-06	9.13e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—melanoma	3.82e-06	8.75e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—melanoma	3.79e-06	8.67e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—melanoma	3.55e-06	8.11e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—melanoma	3.31e-06	7.56e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—melanoma	3.26e-06	7.46e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—melanoma	2.5e-06	5.72e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—melanoma	2.33e-06	5.33e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—melanoma	2.04e-06	4.68e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—melanoma	1.9e-06	4.36e-06	CbGpPWpGaD
